Answers are grounded in this paper and cite their sources.
This article provides a case study on joint production technologies in the market for blood products. The discussion and analysis are motivated by a patent for a plasma-scrubbing tech-nology, acquired solely by the Red Cross. This example of joint production is used to illustrate questions surrounding the leveraging of monopoly power. Specifically, could the Red Cross uti-lize its monopoly over one jointly produced good (scrubbed plasma) to extend market power to a non-monopolized good (red blood cells) when competing with the Blood Centers of America? The case considers the potential for a dual monopoly (by the Red Cross in both markets), limit pricing on the part of the Red Cross in the market for red blood cells, and a shared market in which the Red Cross is a monopoly in the market for plasma but competes with the Blood Centers of America in the market for red blood cells.
No takes yet. Share an insight, caveat, or question.
Lybecker et al. (2007) studied this question.
Synapse has enriched 3 related papers. Consider them for comparative context: